InvestorsHub Logo
Followers 239
Posts 12003
Boards Moderated 0
Alias Born 08/14/2003

Re: Dennisb68 post# 333

Monday, 02/27/2017 4:45:38 PM

Monday, February 27, 2017 4:45:38 PM

Post# of 1106
I believe IMGN will end the year in double digits as more is known about several drugs they and their partners have in trials. The stock could easily reach highs not seen for a few years if the questions about financing are also resolved either by partnering one or more of their drugs, or by a new major partner utilizing their technology.

A Motley Fool article today indicated the price reflects the news that is expected from a technical presentation being made next month with new data from the IMGN853 Phase 1 Trial using the drug in combination with others. The Phase 3 Trial has just begun to dose the first patients.

Gary
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IMGN News